SPINT1 and neoplasm: Importantly, independent research discovered an interaction between Spint1 and membrane-bound serine proteinases to support EMT transitions [9], and inhibition of Spint1 was shown to be of therapeutic benefit by increasing tumor specific immune responses [10].